Table 6 Plasma concentrations of inflammatory biomarkers (TNF-α, IL-6 and MMP-9) at weeks 0, 6 and 12 of the intervention
Rapeseed oil (n = 21) | Sunflower oil (n = 21) | Control (n = 19) | p score1 | p change2 | ||||
|---|---|---|---|---|---|---|---|---|
Score | Δ (change) | Score | Δ (change) | Score | Δ (change) | |||
IL-6 (pg/mL) | ||||||||
Baseline | 1.2 | – | 0.2 | – | 1.2 | – | 0.38 | – |
Week 6 | 1.2 | 0.0 | 1.2 | 0.0 | 1.2 | 0.0 | 0.56 | 0.37 |
Week 12 | 1.2 | 0.0 | 1.2 | 0.0 | 1.2 | 0.0 | 0.34 | 0.23 |
TNF-α (pg/mL) | ||||||||
Baseline | 1.8 (1.8–2.7) | – | 1.8 (1.8–2.6) | – | 2.0 (1.8–2.7) | – | 0.59 | – |
Week 6 | 1.8 (1.8–2.1) | 0.0 | 1.8 (1.8–3.4) | 0.0 (0.0 to 0.5) | 1.8 (1.8–2.7) | 0.0 (− 0.2 to 0.0) | 0.64 | 0.75 |
Week 12 | 1.8 (1.8–2.1) | 0.0 | 1.8 | 0.0 (− 0.3 to 0.0) | 1.8 (1.8–2.7) | 0.0 (− 0.2 to 0.0) | 0.92 | 0.51 |
MMP-9 (ng/ml) | ||||||||
Baseline | 103.3 (81.8–122.5) | – | 100.0 (77.1–134.0) | – | 81.1 (67.1–123.2) | – | 0.60 | |
Week 6 | 95.1 (79.2–123.2) | 3.6 (− 11.4 to 23.9) | 91.2 (72.3–113.0) | − 5.0 (− 28.3 to 14.5) | 83.9 (57.2–116.3) | − 1.1 (− 23.1 to 34.9) | 0.78 | 0.58 |
Week 12 | 74.4 (63.1–126.6) | − 8.3 (− 39.0 to 20.2) | 87.7 (67.2–96.6) | − 27.6 (− 64.5 to 2.2) | 75.0 (56.9–119.0) | − 9.7 (− 30.0 to 14.3) | 0.99 | 0.31 |